Advertisement
Research Article| Volume 43, ISSUE 7, P819-821, July 1994

Uric acid homeostasis in lean and obese girls during pubertal development

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Serum uric acid concentration and fractional excretion were evaluated in lean (n = 67) and obese (n = 56) girls before and during pubertal development. In both lean and obese girls, uricemia gradually increased as puberty advanced. Obese girls were hyperuricemic compared with lean controls (prepubertal: 184 ±83 v 130 ± 29 μmol/L, P = .007; Tanner stage II–III: 190 ± 53 v 178 ± 47 μmol/L, NS; Tanner stage IV–V: 232 ± 53 v 191 ± 53 μmol/L, P = .02). Fractional excretion of urate decreased with puberty in lean girls (6.46% ± 2.29%, 4.61% ± 2.48%, and 3.54% ± 1.84%), but not in obese subjects (3.74% ± 2.27%, 4.01% ± 1.90%, and 4.26% ± 2.26%). Urate homeostasis was similar in prepubertal obese girls and in adolescent lean controls. We conclude that an increased serum urate concentration occurring at puberty may be due to decreased renal clearance of urate in lean girls, and at least in part to urate overproduction in obese subjects. Obesity may prematurely evoke changes in urate metabolism usually observed at puberty.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Scott JT
        Obesity and hyperuricemia.
        Clin Rheum Dis. 1977; 3: 25-35
        • Nicholls A
        • Scott JT
        Effect of weight loss on plasma and urinary levels of uric acid.
        Lancet. 1972; 21: 1223-1224
        • Baldree UA
        • Stapleton FB
        Uric acid metabolism in children.
        Pediatr Clin N Am. 1990; 37: 391-418
        • Stapleton FB
        • Linshaw MA
        • Hassanein K
        • et al.
        Uric acid excretion in normal children.
        J Pediatr. 1978; 92: 911-914
        • Marshall WA
        • Tanner JM
        Variations in patterns of pubertal changes in girls.
        Arch Dis Child. 1969; 44: 291-303
        • Steele TH
        Control of uric acid excretion.
        N Engl J Med. 1971; 284: 1193-1196
        • Armitage P
        ed 3. Statistical Methods in Medical Research. Feltrinelli, Milan, Italy1987
        • Godfrey K
        Simple linear regression in medical research.
        N Engl J Med. 1985; 313: 1629-1636
        • Boss GR
        • Seegmiller JE
        Hyperuricemia and gout. Classification complications and management.
        N Engl J Med. 1979; 300: 1459-1469
        • Scott TJ
        Long-term management of gout and hyperuricemia.
        Br Med J. 1980; 281: 1164-1166
        • Prebis JW
        • Gruskin AB
        • Polinsky MS
        • et al.
        Uric acid in childhood essential hypertension.
        J Pediatr. 1981; 98: 702-707
        • Fox IH
        Metabolic basis for disorders of purine nucleotide degradation.
        Metabolism. 1981; 30: 616-634
        • Kasl SV
        • Cobb S
        • Brooks GW
        Changes in serum uric acid and cholesterol levels in men undergoing job loss.
        JAMA. 1968; 206: 1500-1507
        • Kasl SW
        • Brooks GW
        • Rodgers WL
        Serum uric acid and cholesterol in achievement behavior and motivation. I. The relationship to ability, grades, test performance and motivation.
        JAMA. 1970; 213: 1158-1164
        • Fox IH
        • Palella TD
        • Kelley WN
        Hyperuricemia: A marker for cell energy crisis.
        N Engl J Med. 1987; 317: 111-112
        • Mineo I
        • Kono N
        • Hara N
        • et al.
        Myogenic hyperuricemia: A common pathophysiologic feature of glycogenosis types III, V, and VII.
        N Engl J Med. 1987; 317: 75-80
      1. Montgomery R Dryer RL Conway TW Biochemistry: A Case-Oriented Approach. Edi Ermes, Milan, Italy1975
        • Persky VW
        • Dyer AR
        • Idris-Soven E
        • et al.
        Uric acid: A risk factor for coronary heart disease?.
        Circulation. 1979; 59: 969-972
        • De Fronzo RA
        • Ferrannini E
        Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic vascular disease.
        Diabetes Care. 1991; 14: 173-194
        • Reaven GM
        Role of insulin resistance in human disease.
        Diabetes. 1988; 37: 1595-1607
        • Levine R
        • Hoft DH
        II. Carbohydrate homeostasis.
        N Engl J Med. 1970; 283: 237-246
        • Bougnères PF
        • Artavia-Loria E
        • Henry S
        • et al.
        Increased basal glucose production and utilization in children with recent obesity versus adults with long-term obesity.
        Diabetes. 1989; 38: 477-483
        • Bloch CA
        • Clemmons P
        • Sperling MA
        Puberty reduces insulin sensitivity.
        J Pediatr. 1987; 110: 481-487